Complications and concurrent disease associated with canine hyperadrenocorticism.
In untreated hyperadrenocorticism, clinical problems may result from metastasis of an adrenocortical carcinoma, growth of a pituitary tumor, or complications associated with sustained hypercortisolemia itself, such as hypertension, cardiovascular disease, thromboembolism, glucose intolerance, and increased susceptibility to infection. This article discusses the origin, diagnosis, and treatment of the many complications associated with hyperadrenocorticism.
Nichols
R
R
Antech Diagnostics, Farmingdale, New York, USA.
D000303:Adrenal Cortex Diseases / Q000150:complications / Q000188:drug therapy / Q000662:veterinary*; D000308:Adrenocortical Hyperfunction / Q000150:complications / Q000188:drug therapy / Q000662:veterinary*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000209:etiology / Q000662:veterinary; D004283:Dog Diseases / Q000188:drug therapy / Q000209:etiology*; D004285:Dogs; D005921:Glomerulonephritis / Q000150:complications / Q000209:etiology / Q000662:veterinary; D006333:Heart Failure / Q000150:complications / Q000209:etiology / Q000662:veterinary; D006973:Hypertension / Q000150:complications / Q000209:etiology / Q000662:veterinary; D008939:Mitotane / Q000627:therapeutic use; D010195:Pancreatitis / Q000150:complications / Q000209:etiology / Q000662:veterinary; D011704:Pyelonephritis / Q000150:complications / Q000209:etiology / Q000662:veterinary; D013923:Thromboembolism / Q000150:complications / Q000209:etiology / Q000662:veterinary
D000970:Antineoplastic Agents; D008939:Mitotane